ATE430751T1 - Thienopyridinderivate als allostere gaba-b- enhancer - Google Patents
Thienopyridinderivate als allostere gaba-b- enhancerInfo
- Publication number
- ATE430751T1 ATE430751T1 AT05815262T AT05815262T ATE430751T1 AT E430751 T1 ATE430751 T1 AT E430751T1 AT 05815262 T AT05815262 T AT 05815262T AT 05815262 T AT05815262 T AT 05815262T AT E430751 T1 ATE430751 T1 AT E430751T1
- Authority
- AT
- Austria
- Prior art keywords
- allostere
- gaba
- enhancers
- thienopyridine derivatives
- thienopyridine
- Prior art date
Links
- 239000003623 enhancer Substances 0.000 title 1
- DBDCNCCRPKTRSD-UHFFFAOYSA-N thieno[3,2-b]pyridine Chemical class C1=CC=C2SC=CC2=N1 DBDCNCCRPKTRSD-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04106665 | 2004-12-17 | ||
| PCT/EP2005/013194 WO2006063732A1 (en) | 2004-12-17 | 2005-12-09 | Thieno-pyridine derivatives as gaba-b allosteric enhancers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE430751T1 true ATE430751T1 (de) | 2009-05-15 |
Family
ID=35702999
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05815262T ATE430751T1 (de) | 2004-12-17 | 2005-12-09 | Thienopyridinderivate als allostere gaba-b- enhancer |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7390903B2 (de) |
| EP (1) | EP1828199B1 (de) |
| JP (1) | JP2008524134A (de) |
| KR (1) | KR100912145B1 (de) |
| CN (1) | CN101120003B (de) |
| AR (1) | AR051995A1 (de) |
| AT (1) | ATE430751T1 (de) |
| AU (1) | AU2005315937A1 (de) |
| BR (1) | BRPI0519521A2 (de) |
| CA (1) | CA2591211A1 (de) |
| DE (1) | DE602005014383D1 (de) |
| ES (1) | ES2324231T3 (de) |
| MX (1) | MX2007007026A (de) |
| PL (1) | PL1828199T3 (de) |
| RU (1) | RU2388761C2 (de) |
| TW (1) | TW200633708A (de) |
| WO (1) | WO2006063732A1 (de) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0622472D0 (en) * | 2006-11-10 | 2006-12-20 | Addex Pharmaceuticals Sa | Novel heterocyclic derivatives |
| AU2013202912B2 (en) * | 2007-06-08 | 2016-10-27 | Firmenich Incorporated | Modulation of chemosensory receptors and ligands associated therewith |
| US8633186B2 (en) | 2007-06-08 | 2014-01-21 | Senomyx Inc. | Modulation of chemosensory receptors and ligands associated therewith |
| US7928111B2 (en) | 2007-06-08 | 2011-04-19 | Senomyx, Inc. | Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors |
| US9603848B2 (en) * | 2007-06-08 | 2017-03-28 | Senomyx, Inc. | Modulation of chemosensory receptors and ligands associated therewith |
| WO2010014813A2 (en) | 2008-07-31 | 2010-02-04 | Senomyx, Inc. | Compositions comrpising sweetness enhancers and methods of making them |
| MY153622A (en) | 2008-07-31 | 2015-02-27 | Senomyx Inc | Processes and intermediates for making sweet taste enhancers |
| GB0908394D0 (en) | 2009-05-15 | 2009-06-24 | Univ Leuven Kath | Novel viral replication inhibitors |
| GB0913636D0 (en) | 2009-08-05 | 2009-09-16 | Univ Leuven Kath | Novel viral replication inhibitors |
| NZ603332A (en) | 2010-04-02 | 2014-11-28 | Senomyx Inc | Sweet flavor modifier |
| CN106107406B (zh) | 2010-08-12 | 2020-06-09 | 弗门尼舍公司 | 提高甜味增强剂的稳定性的方法和包含稳定的甜味增强剂的组合物 |
| BR112013011737A2 (pt) | 2010-11-15 | 2016-08-09 | Univ Leuven Kath | composto, uso de um composto composição farmacêutica, e, método de tratamento ou prevenção de uma infecção por hiv |
| CN103429595B (zh) * | 2010-11-15 | 2015-10-21 | Viiv保健英国有限公司 | Hiv复制的抑制剂 |
| EP2742026B1 (de) | 2011-08-12 | 2016-10-05 | Senomyx, Inc. | Süsser geschmacksmodifikator |
| SG11201404630UA (en) * | 2012-02-09 | 2014-09-26 | Merck Patent Gmbh | Furo [3, 2 - b] - and thieno [3, 2 - b] pyridine derivatives as tbk1 and ikk inhibitors |
| NZ703926A (en) | 2012-08-06 | 2018-04-27 | Senomyx Inc | Sweet flavor modifier |
| JO3155B1 (ar) | 2013-02-19 | 2017-09-20 | Senomyx Inc | معدِّل نكهة حلوة |
| EA201690089A1 (ru) | 2013-06-11 | 2017-04-28 | Латвийский Институт Органического Синтеза | ТИЕНО[2,3-b]ПИРИДИНЫ КАК МОДУЛЯТОРЫ СОСТОЯНИЯ МНОЖЕСТВЕННОЙ ЛЕКАРСТВЕННОЙ УСТОЙЧИВОСТИ |
| JP6425724B2 (ja) | 2013-08-08 | 2018-11-21 | ガラパゴス・ナムローゼ・フェンノートシャップＧａｌａｐａｇｏｓ Ｎ．Ｖ． | Ｃｆｔｒモジュレーターとしてのチエノ［２，３−ｃ］ピラン |
| TWI648281B (zh) * | 2013-10-17 | 2019-01-21 | 日商安斯泰來製藥股份有限公司 | 含硫二環式化合物 |
| TW201623257A (zh) | 2014-05-09 | 2016-07-01 | 奧利安公司 | 藥理活性之喹唑啉二酮衍生物 |
| US11339128B2 (en) | 2014-11-07 | 2022-05-24 | Firmenich Incorporated | Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavor modifiers |
| US10927126B2 (en) * | 2016-11-07 | 2021-02-23 | Vanderbilt University | Positive allosteric modulators of the muscarinic acetylcholine receptor M4 |
| WO2020033420A1 (en) | 2018-08-07 | 2020-02-13 | Firmenich Incorporated | 5-substituted 4-amino-1h-benzo[c][1,2,6]thiadiazine 2,2-dioxides and formulations and uses thereof |
| CN109081846A (zh) * | 2018-10-08 | 2018-12-25 | 浙江工业大学上虞研究院有限公司 | 4-氨基噻吩[2,3-b]吡啶类化合物的制备方法 |
| GB202414192D0 (en) | 2024-09-27 | 2024-11-13 | Addex Pharmaceuticals Sa | Novel compounds |
| GB202414193D0 (en) | 2024-09-27 | 2024-11-13 | Addex Pharmaceuticals Sa | Novel compounds |
| GB202414199D0 (en) | 2024-09-27 | 2024-11-13 | Addex Pharmaceuticals Sa | Novel Compounds |
| GB202414197D0 (en) | 2024-09-27 | 2024-11-13 | Addex Pharmaceuticals Sa | Novel compounds |
| GB202414200D0 (en) | 2024-09-27 | 2024-11-13 | Addex Pharmaceuticals Sa | Novel compounds |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1003419A (en) * | 1971-11-23 | 1977-01-11 | Theodor Denzel | Process for the production of pyrazolo (3,4-b) pyridines |
| GB8801491D0 (en) * | 1988-01-22 | 1988-02-24 | Beecham Group Plc | Novel compounds |
| GB8804448D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| GB8921304D0 (en) * | 1989-09-20 | 1989-11-08 | Wyeth John & Brother Ltd | New method of treatment and heterocyclic compounds used therein |
| US6313146B1 (en) * | 1991-08-23 | 2001-11-06 | Nps Pharmaceuticals, Inc. | Calcium receptor-active molecules |
| PT101034A (pt) * | 1991-11-07 | 1994-02-28 | Smithkline Beecham Plc | Composicoes farmaceuticas contendo tetra-hidropiridinas, tetra-hidropiridinas ai utilizadas , processo para a sua preparacao e sua utilizacao como medicamentos |
| CA2202985A1 (en) * | 1994-11-08 | 1996-05-17 | Haruhiko Makino | Thienopyridine or thienopyrimidine derivatives and their use |
| FR2800072B1 (fr) * | 1999-10-22 | 2002-01-11 | Centre Nat Rech Scient | 1-(2-butyrolactones et 2-thiobutyrolactones)-isoquinolines n-substituees utiles comme stimulant de l'activite de l'acide gamma-aminobutyrique et dans le traitement des troubles nerveux et leur procede de preparation |
| US6800651B2 (en) | 2000-02-03 | 2004-10-05 | Eli Lilly And Company | Potentiators of glutamate receptors |
| TW591031B (en) * | 2000-02-29 | 2004-06-11 | Takeda Chemical Industries Ltd | Thienopyridine derivatives, their production and use |
| WO2002014269A2 (en) * | 2000-08-16 | 2002-02-21 | Neurogen Corporation | 2,4-substituted pyridine derivatives |
| GB0209481D0 (en) | 2002-04-24 | 2002-06-05 | Novartis Ag | Organic compounds |
-
2005
- 2005-12-09 MX MX2007007026A patent/MX2007007026A/es active IP Right Grant
- 2005-12-09 WO PCT/EP2005/013194 patent/WO2006063732A1/en not_active Ceased
- 2005-12-09 AT AT05815262T patent/ATE430751T1/de active
- 2005-12-09 ES ES05815262T patent/ES2324231T3/es not_active Expired - Lifetime
- 2005-12-09 BR BRPI0519521-7A patent/BRPI0519521A2/pt not_active IP Right Cessation
- 2005-12-09 PL PL05815262T patent/PL1828199T3/pl unknown
- 2005-12-09 CN CN2005800481208A patent/CN101120003B/zh not_active Expired - Fee Related
- 2005-12-09 JP JP2007545902A patent/JP2008524134A/ja active Pending
- 2005-12-09 DE DE602005014383T patent/DE602005014383D1/de not_active Expired - Lifetime
- 2005-12-09 RU RU2007121908/04A patent/RU2388761C2/ru not_active IP Right Cessation
- 2005-12-09 CA CA002591211A patent/CA2591211A1/en not_active Abandoned
- 2005-12-09 KR KR1020077016010A patent/KR100912145B1/ko not_active Expired - Fee Related
- 2005-12-09 EP EP05815262A patent/EP1828199B1/de not_active Expired - Lifetime
- 2005-12-09 AU AU2005315937A patent/AU2005315937A1/en not_active Abandoned
- 2005-12-13 US US11/301,696 patent/US7390903B2/en not_active Expired - Fee Related
- 2005-12-14 TW TW094144190A patent/TW200633708A/zh unknown
- 2005-12-15 AR ARP050105260A patent/AR051995A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20070091016A (ko) | 2007-09-06 |
| DE602005014383D1 (en) | 2009-06-18 |
| CN101120003B (zh) | 2010-06-16 |
| EP1828199B1 (de) | 2009-05-06 |
| WO2006063732A1 (en) | 2006-06-22 |
| PL1828199T3 (pl) | 2009-10-30 |
| MX2007007026A (es) | 2007-07-04 |
| AU2005315937A1 (en) | 2006-06-22 |
| TW200633708A (en) | 2006-10-01 |
| EP1828199A1 (de) | 2007-09-05 |
| US20060135552A1 (en) | 2006-06-22 |
| RU2007121908A (ru) | 2009-01-27 |
| ES2324231T3 (es) | 2009-08-03 |
| KR100912145B1 (ko) | 2009-08-14 |
| JP2008524134A (ja) | 2008-07-10 |
| RU2388761C2 (ru) | 2010-05-10 |
| CA2591211A1 (en) | 2006-06-22 |
| US7390903B2 (en) | 2008-06-24 |
| CN101120003A (zh) | 2008-02-06 |
| BRPI0519521A2 (pt) | 2009-02-10 |
| AR051995A1 (es) | 2007-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE400271T1 (de) | Aryl-pyridinderivate als 11-beta-hsd1-hemmer | |
| ATE460417T1 (de) | Acetylenylpyrazolopyrimidinderivate als mglur2- antagonsten | |
| ATE509627T1 (de) | Zusammensetzungen mit nebivolol | |
| ATE420076T1 (de) | Indozolonderivate als 11b-hsd1-inhibitoren | |
| ATE452631T1 (de) | N-2-adamantanyl-2-phenoxy-acetamid-derivate als 11-betahydroxysteroid-dehydrogenase-hemmer | |
| IS8578A (is) | 3- karbamoýl - 2- pýridón afleiður | |
| ATE501138T1 (de) | Thiophenderivate als chk-1-inhibitoren | |
| EP1788047A4 (de) | Wasserabweisende/ölabweisende zusammensetzung | |
| ATE394399T1 (de) | Tetrahydropyridoindolderivate | |
| PL1828199T3 (pl) | Pochodne tieno-pirydyny jako alosteryczne wzmacniacze gaba-b | |
| ATE540935T1 (de) | Chinazolinderivate | |
| DK1761541T3 (da) | Pyrrazolo-pyrimidin-derivater | |
| ATE512960T1 (de) | Pyrimidinderivate | |
| DK1804871T3 (da) | Forbedret mellemstykke | |
| ATE417830T1 (de) | Sulfonylbenzimidazolderivate | |
| DE602005020768D1 (de) | Flammfestes kunstleder | |
| ATE509011T1 (de) | Pyrimidinderivate als 11beta-hsd1-inhibitoren | |
| DE602005008986D1 (de) | Substituierte hydantoine | |
| ATE396724T1 (de) | 1h-thieno 2,3-c-pyrazol-derivate als kinase-i- hemmer | |
| ATE430142T1 (de) | Phenylpiperazin-methanon-derivate | |
| IL187425A0 (en) | 3-methanesulfonylquinolines as gaba-b enhancers | |
| FI20040071A0 (fi) | Kytkinlaitemoduuli | |
| DE602005017191D1 (de) | Geruchsreduzierte waschstück-zusammensetzung | |
| ATE404542T1 (de) | 4-phenylpyrimidin-2-carbonitrilderivate | |
| ATE365731T1 (de) | 4-amino-5-cyanopyrimidinderivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1828199 Country of ref document: EP |